Company Sector
Radiopharmaceuticals
Radiopharmaceuticals includes companies pairing radioactive payloads with targeted delivery approaches for imaging or treatment, especially in oncology. It is a closely watched category because it combines precision targeting with differentiated procedural and therapeutic economics.
Why watch Radiopharmaceuticals
This page combines a company index, a watch action, and the newest relevant feed items in one place so readers can monitor a biotech theme without scanning each company one by one.
Latest Radiopharmaceuticals news
The latest feed items from companies currently grouped under Radiopharmaceuticals.
- 01
CATXPerspective Therapeutics to Provide Business Highlights and Report Second Quarter 2026 Financial Results
Source: Perspective Therapeutics
- 02
CATXPerspective Therapeutics Receives European Orphan Medicinal Product Designation for [212Pb]VMT-α-NET in GEP-NETs
Source: Perspective Therapeutics
- 03
CATXPerspective Therapeutics Announces Acceptance of VMT-α-NET Data for Oral Presentation at the ESMO Congress 2026
Source: Perspective Therapeutics
- 04
- 05
- 06
- 07
CATXPerspective Therapeutics Announces First Patients Dosed in New Cohorts of Two Ongoing Phase 1/2a Studies
Source: Perspective Therapeutics
- 08
CATXPerspective Therapeutics Provides Recent Business Highlights and Reports 1Q 2026 Results
Source: Perspective Therapeutics
- 09
CATXPerspective Therapeutics to Provide Several Upcoming Corporate Updates
Source: Perspective Therapeutics
- 10
- 11
CATXPerspective Therapeutics to Participate in Upcoming Investor Conferences
Source: Perspective Therapeutics
- 12
CATXPerspective Therapeutics Announces Acceptance of VMT-α-NET Data for Presentation at the AACR Annual Meeting 2026
Source: Perspective Therapeutics
- 13
CATXPerspective Therapeutics Provides Recent Business Highlights and Reports Full Year 2025 Results
Source: Perspective Therapeutics
- 14
CATXPerspective Therapeutics to Provide Business Highlights and Report Full Year 2025 Financial Results
Source: Perspective Therapeutics
- 15
CATXPerspective Therapeutics Announces Pricing of $175 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
Source: Perspective Therapeutics
- 16
- 17
- 18
CATXPerspective Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
Source: Perspective Therapeutics
- 19
- 20
CATXPerspective Therapeutics to Participate in Upcoming December Conferences
Source: Perspective Therapeutics
Companies in Radiopharmaceuticals
4 companies tagged with Radiopharmaceuticals.
Frequently Asked Questions
What does the Radiopharmaceuticals sector include?
Radiopharmaceuticals includes companies pairing radioactive payloads with targeted delivery approaches for imaging or treatment, especially in oncology. It is a closely watched category because it combines precision targeting with differentiated procedural and therapeutic economics.
How many companies are currently tagged with Radiopharmaceuticals?
4 companies are currently grouped under Radiopharmaceuticals on BioPharmSignal.
Which companies are most visible in the Radiopharmaceuticals group right now?
FUSN, LNTH, CATX, RYZB are among the companies currently shown on this sector page.
How can I watch news for Radiopharmaceuticals?
Use the Watch button on this page to subscribe to Radiopharmaceuticals headlines and related company updates through your BioPharmSignal saved filters.
What kinds of updates usually appear for Radiopharmaceuticals?
The livefeed typically surfaces company press releases, clinical readouts, FDA and regulatory updates, partnerships, financings, and commercialization developments tied to companies in Radiopharmaceuticals.